A Study of MHB009C in Patients With Advanced Solid Tumors

Clinical trial NCT07326488 · RECRUITING

Trial details

NCT number: NCT07326488
Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Malignant Solid Tumor

Start date: 2026-03-17
Primary completion: 2028-02-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.